Washington, D.C. — Presidential candidate Robert F. Kennedy Jr. announced a new initiative this week, proposing that he personally oversee the gradual reduction of antidepressant dosages for all Americans currently taking the medication. Citing concerns about long-term usage, Kennedy detailed a vision for a national, individualized tapering program he would directly manage, starting with weekly check-ins via a soon-to-be-launched "Mindful Mood Management" app.
“The American people deserve a leader who isn’t afraid to roll up his sleeves and get into the trenches with them, one serotonin molecule at a time,” Kennedy stated during a livestream from an organic quinoa farm. “I’m prepared to dedicate my entire presidency, if necessary, to guiding each and every one of our citizens off these pharmaceutical crutches and back to their natural state of joy, powered by sunshine and artisanal hemp paper mood journals.”
Experts immediately noted the immense logistical challenge. “To put this into perspective, we’re talking about overseeing the medication adjustments of more than 44 million individuals, each with unique neurological profiles, medical histories, and potential withdrawal symptoms,” explained Dr. Aris Thorne, head of psychiatric logistics at the American Institute of Neuropharmaceutical Policy. “It’s like promising to personally teach 330 million people how to perfectly parallel park their cars simultaneously. The hubris required is almost as staggering as the sheer volume of SSRIs prescribed last year.”
A spokesperson for the Kennedy campaign, Kaelan O’Malley, clarified that while Kennedy would “ideally” be present for every single tapering conversation, logistical realities might require him to delegate initial consultations to “Certified Serotonin Reuptake Inhabitor Withdrawal Coaches.” These coaches, O’Malley explained, would be trained in a rigorous three-day online course focusing on positive affirmations, gut microbiome health, and the potential benefits of cold-water immersion. “The goal is to empower Americans to take control of their emotional well-being, one saffron-infused positivity elixir at a time,” O’Malley added, noting that the program’s funding would come from a proposed tax on “Big Pharma’s unnecessary happiness.”
Psychiatrists across the nation have begun clearing their schedules, anticipating a surge in appointments from patients who have already mentally committed to avoiding Kennedy’s direct therapeutic oversight at all costs.
